BeStock  

Elanco Animal Health ELAN

US equityMarket cap rank #1233Drug Manufacturers - Specialty & Generic
$25.74 −$0.55 (-2.09%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $25.22 -2.04%
Open$26.22
Prev close$26.29
Day range$25.58 – $26.93
Volume5.83M
Market cap$12.87B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership111.9%-2.42 pts vs. prior quarter
Institutions holding621+12 vs. prior quarter
Insider trades (recent)48 buys / 2 sellsNet buying
Short interest6.59% of floatDays to cover 7.2 · as of 30 Oct 2026
Short-sale volume share18.0%5-day average of daily volume

Short-sale volume as % of daily volume

9%16%24%31%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$20.07M (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

+$30.8MSuper−$10.7MBig−$5.2MMid−$2.3MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 49.1% of shares outstanding.

Largest holders

  • Dodge & Cox12.29%
  • FMR11.86%
  • BlackRock9.86%
  • PRIMECAP Management Company9.09%
  • T. Rowe Price Group, Inc.6.03%
  • Dimensional Fund Advisors5.02%
  • Vanguard Portfolio Management, LLC4.62%
  • Vanguard Capital Management, LLC4.51%

By investor type

  • Mutual Fund99.25%
  • Hedge Fund6.91%
  • Public Company3.09%
  • Government Pension Fund1.08%
  • Individual/Insider0.71%
  • Private Company0.70%
  • Insurance Company0.37%
  • Family Office/Trust0.24%

Reported short interest has risen from 5.95% to 6.59% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
FMR Mutual Fund 2026/Q3 +9,757,826 11.9%
Artemis Investment Management LLP Mutual Fund 2026/Q3 +1,645,331 0.9%
Wilshire Advisors LLC Mutual Fund 2026/Q3 +1,144,784 0.2%
Jupiter Fund Management Plc Mutual Fund 2026/Q3 +850,405 1.0%
Bowen, Hanes & Company, Inc. Mutual Fund 2026/Q3 +797,945 0.7%
Voya Investment Management LLC Mutual Fund 2026/Q3 +784,974 0.2%
Thrivent Investment Management, Inc. Mutual Fund 2026/Q3 +542,529 0.3%
Citadel Advisors LLC Hedge Fund 2026/Q3 +5,281,484 1.9%
FMR Mutual Fund 2026/Q3 +3,394,229 9.9%
Marshall Wace LLP Hedge Fund 2026/Q3 +3,049,938 0.9%
Morgan Stanley Public Company 2026/Q3 +2,733,843 1.1%
Strategic Advisers LLC Mutual Fund 2026/Q3 +2,629,224 1.5%
Black Creek Investment Management Inc. Mutual Fund 2026/Q3 +2,552,571 2.6%
Freestone Grove Partners LP Hedge Fund 2026/Q3 +2,170,681 0.4%
Manulife Asset Management Mutual Fund 2026/Q3 +2,126,727 1.7%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
29 Oct 2026 Jeffrey Simmons Chief Executive Officer Other Derivative Acquisition +122 – 25,742
29 Oct 2026 Robert VanHimbergen Chief Financial Officer Other Derivative Acquisition +8 – 184
29 Oct 2026 Rajeev Modi Executive Vice President of U.S. Pet Health & Global Digital Transformation Other Derivative Acquisition +64 – 10,090
15 Oct 2026 Jeffrey Simmons Chief Executive Officer Other Derivative Acquisition +120 – 25,619
15 Oct 2026 Robert VanHimbergen Chief Financial Officer Other Derivative Acquisition +8 – 176
15 Oct 2026 Rajeev Modi Executive Vice President of U.S. Pet Health & Global Digital Transformation Other Derivative Acquisition +62 – 10,026
14 Oct 2026 Timothy Bettington Executive Vice President of Center of Strategic Growth Automatic Disposition -4,350 $23.00 101,532
14 Oct 2026 Timothy Bettington Executive Vice President of Center of Strategic Growth Intent to Sell (Form 144) -4,350 $23.00 –
1 Oct 2026 Jeffrey Simmons Chief Executive Officer Other Derivative Acquisition +127 – 25,499
1 Oct 2026 Robert VanHimbergen Chief Financial Officer Other Derivative Acquisition +8 – 168
1 Oct 2026 Rajeev Modi Executive Vice President of U.S. Pet Health & Global Digital Transformation Other Derivative Acquisition +66 – 9,963
29 Sep 2026 Kapila Anand Independent Director Other Derivative Acquisition +642 – 10,722
17 Sep 2026 Jeffrey Simmons Chief Executive Officer Other Derivative Acquisition +126 – 25,372
17 Sep 2026 Robert VanHimbergen Chief Financial Officer Other Derivative Acquisition +8 – 159
17 Sep 2026 Rajeev Modi Executive Vice President of U.S. Pet Health & Global Digital Transformation Other Derivative Acquisition +65 – 9,896
3 Sep 2026 Jeffrey Simmons Chief Executive Officer Other Derivative Acquisition +115 – 25,246
3 Sep 2026 Robert VanHimbergen Chief Financial Officer Other Derivative Acquisition +8 – 150
3 Sep 2026 Rajeev Modi Executive Vice President of U.S. Pet Health & Global Digital Transformation Other Derivative Acquisition +60 – 9,831
20 Aug 2026 Jeffrey Simmons Chief Executive Officer Other Derivative Acquisition +117 – 25,130
20 Aug 2026 Robert VanHimbergen Chief Financial Officer Other Derivative Acquisition +8 – 142

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 32,923,699 6.6% 7.2
15 Oct 2026 31,106,655 6.2% 6.4
30 Sep 2026 37,291,528 7.5% 6.2
15 Sep 2026 31,809,151 6.4% 6.3
31 Aug 2026 30,920,811 6.2% 6.4
14 Aug 2026 29,719,014 5.9% 2.5

Discussion

No comments yet — be the first to weigh in on ELAN.

Sign in to join the discussion.

Scroll to Top